Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.
about
MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cellsBreast cancer stem-like cells: clinical implications and therapeutic strategiesIdentifying and targeting tumor-initiating cells in the treatment of breast cancerSLUG: Critical regulator of epithelial cell identity in breast development and cancerTargeting SH2 domains in breast cancerHuman correlates of provocative questions in pancreatic pathologyEndothelial protein C receptor function in murine and human breast cancer developmentNanomedicine-Mediated Therapies to Target Breast Cancer Stem CellsCancer in light of experimental evolutionPhenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancerSpontaneous epithelial-mesenchymal transition and resistance to HER-2-targeted therapies in HER-2-positive luminal breast cancer.Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype.Hypermutable DNA chronicles the evolution of human colon cancer.Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less.The therapeutic implications of plasticity of the cancer stem cell phenotype.Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancerAldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancerEvolutionary dynamics of intratumor heterogeneity.Clinicopathologic characteristics of breast cancer stem cells identified on the basis of aldehyde dehydrogenase 1 expression.CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer.Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium.TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis.Correlations of ALDH1 expression with molecular subtypes and ABCG2 in breast cancerVimentin DNA methylation predicts survival in breast cancerEndothelial cell protein C receptor: a multiliganded and multifunctional receptorCSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancerSequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo.Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors.Phenotypic heterogeneity of breast cancer stem cells.Histological, molecular and functional subtypes of breast cancersRole of the protein C receptor in cancer progression.Inhibition of histone H3K79 methylation selectively inhibits proliferation, self-renewal and metastatic potential of breast cancerMapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell linesEpithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer.A functional in vivo screen for regulators of tumor progression identifies HOXB2 as a regulator of tumor growth in breast cancerA new strategy using ALDHhigh-CD8+T cells to inhibit tumorigenesis.New concepts in breast cancer genomics and geneticsInsight into the heterogeneity of breast cancer through next-generation sequencing.Models of breast morphogenesis based on localization of stem cells in the developing mammary lobule
P2860
Q24336566-3C2C4ADE-7EB0-4BD2-902F-5E91E6C9625AQ26752170-D9C6951E-24B3-46D7-903C-61E18D05FCCAQ26851827-14811185-3EFE-4FF2-889C-EF15CDC6F7BAQ26865846-05DF9678-5040-43B1-A055-4E7A56A57FABQ27014674-185B8368-2FEE-4D56-B97A-1127F607581BQ27023576-ED65D40C-BBD4-4DE2-A0CC-FCFB0873364AQ27327182-0D32170B-0072-4708-9DA5-C7B706424868Q28066297-0195CBF6-66B2-48A2-9C49-5242D2B67F95Q28727500-F5788746-DA4F-4E4E-8AC5-B5636F56D0BFQ29619481-CC4DD3FA-8B5F-4173-986E-67DBB627B574Q31132069-11B0ED6F-E374-4CCF-8390-E12EB0E6BFF7Q33604942-ACC76146-147B-4A55-A0FE-B2BA059DDB4AQ33606821-6A644E6A-E8DF-494A-8367-0B4376B07DECQ33718750-825B79F7-C107-411A-B3D3-0C8A73328AA6Q33778409-804A58FE-0270-45DA-801E-CB5BEFFD7ECEQ33798788-27F088DD-5D51-431C-9B24-005D66311F30Q33833666-F468A515-CF9E-405F-9A8E-AECDD661B174Q33867413-DA09CA8B-BCE7-4454-996D-C7189FFB13F7Q33875805-2001DF70-2766-4265-A823-CAC9293D066FQ33888775-D06DB36C-44D1-4610-9A90-22239C8EF6E6Q33892734-4970A787-A9D1-42CE-85CF-7EFCFC5A5F45Q33955287-A70C456F-71D8-4CC8-9FF3-7411F8899D8DQ33972932-BE67C55C-1316-4666-AAA1-C52F2F4B452FQ34034767-629CA3BC-5907-4407-A9B3-1D410A3F8896Q34136982-92EF24CA-8A3B-4472-9233-880C23CF4DAFQ34176395-9FE35E2C-6D3E-4EE9-B4D0-616ED55A3239Q34485861-A2561889-4393-45F9-AF75-82FC4F2261DBQ34500251-05C633B5-0CC0-40B8-BD59-B972781D2F9BQ34521202-1FC0CB82-6863-4309-86B3-2FB0D9B54116Q34616569-42FB9CFA-6F91-4146-95DF-6F43839D925CQ34731385-3C1CC481-0073-4107-8C04-A29305064658Q34786534-C9BAD48B-EDC1-4C86-BC67-9E00723B1F55Q34989167-5774B46C-D08B-4F97-9528-5B1748473B49Q35029475-749A691F-AE3F-4D62-B974-5F701C3A9EDDQ35034623-EB2EF6AF-A465-47DC-89BA-EC5DCF692C5CQ35190545-3025CD59-A0C2-448C-91F6-71A94500B017Q35221936-D9726735-8DD5-4F62-ACCA-981CFC2EAC9EQ35258057-210D41C6-9863-4A2B-846A-97B039D05B4CQ35370090-FE80730B-A9E2-488B-A48D-7CCB86049E83Q35453612-BFFAF81D-01D1-4098-966D-B1A0CA5BE04F
P2860
Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Heterogeneity for stem cell-re ...... ologic stage in breast cancer.
@ast
Heterogeneity for stem cell-re ...... ologic stage in breast cancer.
@en
type
label
Heterogeneity for stem cell-re ...... ologic stage in breast cancer.
@ast
Heterogeneity for stem cell-re ...... ologic stage in breast cancer.
@en
prefLabel
Heterogeneity for stem cell-re ...... ologic stage in breast cancer.
@ast
Heterogeneity for stem cell-re ...... ologic stage in breast cancer.
@en
P2093
P2860
P1476
Heterogeneity for stem cell-re ...... tologic stage in breast cancer
@en
P2093
Hee Eun Lee
Kornelia Polyak
Michail Shipitsin
Rebecca Gelman
P2860
P304
P356
10.1158/1078-0432.CCR-09-1532
P407
P50
P577
2010-01-26T00:00:00Z